Company profile: Target RWE
1.1 - Company Overview
Company description
- Provider of real-world evidence solutions evaluating drug use in hospitals and other healthcare settings, including longitudinal community registries, syndicated RWE analytics, a biorepository of 150,000+ biospecimen samples linked to de-identified clinical data, patient-generated data, advanced analytics via Population Health Research Applications, and custom epidemiological studies for development, regulatory, and post-marketing safety.
Products and services
- Custom Solutions: Custom-engineered real-world evidence services encompassing advanced epidemiological studies to support drug development, meet regulatory demands, and address post-marketing safety requirements across diverse healthcare settings
- Community Registries: Longitudinal, observational registries tracking patient journeys for over 8 years, enabling partners to engage disease communities and access real-world datasets from hospital and broader healthcare settings
- Biorepository: Large-scale biospecimen collection comprising over 150,000 samples linked to de-identified clinical data, available for laboratory testing and research
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Target RWE
ClinicalRM
HQ: United States
Website
- Description: Provider of full-service contract research solutions specializing in preclinical through Phase IV support of clinical research and clinical trial services for biologics, drugs, and devices, offering a wide array of research, regulatory, and sponsor services within the U.S. to help customers get products to market faster.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ClinicalRM company profile →
mdgroup
HQ: United Kingdom
Website
- Description: Provider of professional services to a wide range of industries, with a focus in the life sciences sector. Women-owned, independent global organisation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full mdgroup company profile →
Evaluate
HQ: United Kingdom
Website
- Description: Provider of trusted commercial intelligence for the pharmaceutical and medical device industries, offering EvaluatePharma online subscription services that deliver a standardized view of the global pharmaceutical market's past, present, and future. Offerings include data feeds integrating forecast, trial, and key event data, asset screening, competitive landscape analysis, commercial opportunity assessment, company profiling, and data-driven thought leadership.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Evaluate company profile →
Cambrex
HQ: United States
Website
- Description: Provider of end-to-end small molecule drug substance and drug product development and manufacturing, analytical services and testing, IND-enabling services, and process development. Supports research through commercial scale, covering various dosage forms, streamlining IND submissions, and ensuring regulatory compliance and product safety for small molecule therapeutics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cambrex company profile →
Two Labs
HQ: United States
Website
- Description: Provider of pharmaceutical services including market access, market intelligence, commercialization, and medical affairs & communications for pharmaceutical manufacturers. Offerings include channel strategy, state licensing, compendia listings, publication support, payer/physician/patient strategies, disease and competitor insights, Riparian government pricing/contracting/transparency, and specialty pharmacy network selection; led 200+ launches and 290+ in-market projects.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Two Labs company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Target RWE
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Target RWE
2.2 - Growth funds investing in similar companies to Target RWE
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Target RWE
4.2 - Public trading comparable groups for Target RWE
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →